12/27/11 The long-awaited day has arrived! For more than seven years, friends and followers of the late John Kanzius have been waiting for the day that the “Kanzius Cancer-Killing Machine” would be ready and able to test larger laboratory subjects and ultimately humans. The wait is over according to Executive Director of the Research Foundation, Mark Neidig (1978 PHS Grad)!
During a press conference held last week in Erie, Pennsylvania, Marianne Kanzius, John’s surviving spouse and managing partner of Therm Med, announced that GenV of the Kanzius RF Machine was built and ready to ship
GenV is the fifth model of a machine that has been developed as a result of John’s “ah hah” moment that targeted cancer cells could be destroyed using radiowaves. This new machine, which has a testing subject capacity of up to 800 pounds in weight, is destined for our labs in Houston at The University of Texas MD Anderson Cancer Center, where testing will begin next month.
What does this mean for the research and human trials?
This is major breakthrough in the journey to human trials. We have all been waiting for a machine capable of testing/treating a human; now we have that. Research in 2012 will be the most intense ever – more tests, more validations, more researchers, more money – all with the goal of producing credible outcomes, in larger non-human subjects, to present to the FDA. The momentum is building and your donation today will assure the continuum of progress.
Please make your tax-deductible donation now!
Neidig said, “We believe there has to be a better way to treat cancer!” He closed by saying, “Thank you for your continued help; hope can become reality!”
Photo: Explaining the workings of the new GenV are l-r, Mike Nelson (consultant with RedWind Innovations), Marianne Kanzius (managing partner, Therm Med) and Charlie Rutkowski (VP, Industrial Sales and Mfg.)
